In the context of autophagy, a previous study showed that autophagy inhibition by hydroxychloroquine and knockdown of ATG5 or ATG7 decreased tumor cell survival in AML harboring wild-type TP53, but not in mutated TP53 [119]. This evidence concerns the gene TP53 and acute myeloid leukemia.